François B, Garcia Sanchez M, Eggimann P, et al. Suvratoxumab reduces staphylococcus aureus pneumonia in high-risk icu patients: results of the SAATELLITE Study. Am J Resp Crit Care Med. 2019;199:A7358.
Tezepelumab bij ernstig, ongecontroleerd astma: gepoolde analyse van PATHWAY en NAVIGATOR
okt 2023 | Astma